ARA-290 (Cibinetide) – For Research Use Only

ARA-290 is a synthetic 11-amino acid peptide derived from the tissue-protective region of erythropoietin (EPO). Unlike EPO, ARA-290 was specifically engineered to activate the body’s Innate Repair Receptor (IRR) without stimulating red blood cell production, making it a unique compound for researchers investigating inflammation, nerve repair, and tissue regeneration pathways.

Current research has explored ARA-290 in experimental models involving small fiber neuropathy, neuroinflammation, metabolic dysfunction, vascular injury, and autoimmune-related tissue damage. By selectively activating the IRR, investigators have observed signaling associated with reduced inflammatory cytokine activity, cellular protection, and support for the body’s natural repair mechanisms, all without the erythropoietic effects associated with traditional erythropoietin.

Although early clinical studies have shown encouraging findings in select conditions such as neuropathic pain and sarcoidosis-associated small fiber neuropathy, ARA-290 remains an investigational compound, and additional research is necessary to fully understand its mechanisms and broader applications.

Product Specifications

Compound: ARA-290 (Cibinetide)

Purity: ≥99% (HPLC Tested)

Form: Lyophilized powder

Research Grade: Manufactured under stringent quality standards

For Research Use Only

This product is intended strictly for laboratory and scientific research purposes. It is not intended for human or veterinary use, therapeutic applications, or diagnostic procedures. RH Peptides supplies research materials exclusively to qualified researchers and institutions.